Compare AdaptHealth Corp (AHCO) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Standard Lithium Ltd — how do they compare? AdaptHealth Corp trades at $10.05 (market cap $1.38B), while Standard Lithium Ltd trades at $2.49 (market cap $592.60M). The key difference: AdaptHealth Corp is far larger — about 2.3× Standard Lithium Ltd's market cap, and AdaptHealth Corp is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| AHCO | SLI | |
|---|---|---|
Market Cap | $1.38B | $592.60M |
Sector | Health | Basic Materials |
52-Week High | $13.38 | $5.65 |
52-Week Low | $8.68 | $2.29 |
Enterprise Value | $3.33B | $451.80M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Standard Lithium (SLI) trades at $2.68, down 1.47% on the day, with a bearish technical signal from moving averages despite some bullish oscillators. The company reported a net loss of $48.40 million in 2025, with negative ROE and ROA, but maintains a P/B ratio of 1.8. Recent news highlights progress on its South West Arkansas lithium project, including a $225 million DOE grant and key construction contracts, positioning it for a final investment decision in 2026.
The investment case hinges on successful project execution and lithium market dynamics, with 100% analyst buy ratings signaling strong growth potential. Key risks include persistent negative cash flow from operations, high capital expenditures, and execution delays. Upside depends on timely project completion and favorable lithium pricing, while downside risks involve funding gaps and operational setbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
